Juergen Prattes
Overview
Explore the profile of Juergen Prattes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prattes J, Giacobbe D, Marelli C, Signori A, Dettori S, Cattardico G, et al.
Mycoses
. 2025 Jan;
68(1):e70023.
PMID: 39800852
Background: This study investigated the impact of posaconazole (POSA) prophylaxis in COVID-19 patients with acute respiratory failure receiving systemic corticosteroids on the risk for the development of COVID-19-associated pulmonary aspergillosis...
2.
Weaver D, Gago S, Bassetti M, Giacobbe D, Prattes J, Hoenigl M, et al.
Microbiol Spectr
. 2024 Dec;
13(2):e0411023.
PMID: 39699254
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a life-threatening complication in patients with severe COVID-19. Previously, acute respiratory distress syndrome in patients with COVID-19 has been associated with lung...
3.
Schub T, Klugherz I, Wagener J, Prattes J, Hoenigl M, Suerbaum S, et al.
J Clin Microbiol
. 2024 Nov;
62(12):e0095024.
PMID: 39494863
Invasive aspergillosis (IA) is a life-threatening infection. Early and specific diagnosis is pivotal to ensure adequate therapy. Antigen testing from blood is a widespread and convenient diagnostic approach. Various tests...
4.
Serris A, Rautemaa-Richardson R, Laranjinha J, Candoni A, Garcia-Vidal C, Alastruey-Izquierdo A, et al.
Clin Infect Dis
. 2024 Jul;
79(4):936-943.
PMID: 39076104
Background: Cerebral aspergillosis (CA) is associated with high mortality. According to the European Conference on Infections in Leukemia and the European Society of Clinical Microbiology and Infectious Diseases guidelines, the...
5.
Sedik S, Boyer J, Egger M, Dichtl K, Prattes J, Pruller F, et al.
Mycopathologia
. 2024 Jul;
189(4):67.
PMID: 39023825
Background: Galactomannan (GM) testing using Platelia Aspergillus enzyme immunoassay (Platelia AGM) from bronchoalveolar lavage fluid (BALF) aids in early diagnosis of invasive pulmonary aspergillosis (IPA). Globally, only a minority of...
6.
Prattes J, Giacobbe D, Bassetti M, Gangneux J, Hoenigl M
Intensive Care Med
. 2024 Jul;
50(8):1375-1377.
PMID: 38980361
No abstract available.
7.
Boyer J, Sedik S, Egger M, Dichtl K, Prattes J, Kriegl L, et al.
Mycoses
. 2024 Jun;
67(6):e13756.
PMID: 38886163
Background: Serum galactomannan (GM) testing is essential for diagnosing invasive aspergillosis (IA), particularly in immunocompromised individuals. The global lack of on-site GM testing capacities necessitates cost-effective alternatives, such as .the...
8.
Lahmer T, Salmanton-Garcia J, Marchesi F, El-Ashwah S, Nucci M, Besson C, et al.
Infection
. 2024 May;
52(3):1191-1194.
PMID: 38771466
No abstract available.
9.
Hoenigl M, Arastehfar A, Arendrup M, Bruggemann R, Carvalho A, Chiller T, et al.
Clin Microbiol Rev
. 2024 Apr;
37(2):e0007423.
PMID: 38602408
SUMMARYFungal infections are on the rise, driven by a growing population at risk and climate change. Currently available antifungals include only five classes, and their utility and efficacy in antifungal...
10.
Salmanton-Garcia J, Marchesi F, Farina F, Weinbergerova B, Itri F, Davila-Valls J, et al.
EClinicalMedicine
. 2024 Mar;
71:102553.
PMID: 38533127
Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals,...